Results of initial doxorubicin, 5‐fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

Cancer

Volumn 65, Issue 4, 1990, Pages 851-855

  Maloisel, F ^a   Dufour, P ^a   Bergerat, J P ^a   Herbrecht, R ^a   Duclos, B ^a   Boilletot, A ^a   Giron, C ^a   Haennel, P ^a   Oberling, F ^a   Jaeck, D ^a   Jung, G ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Department of Oncological Surgery   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMAN; MIDDLE AGE;

EID: 0025134218     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19900215)65:4<851::AID-CNCR2820650403>3.0.CO;2-O     Document Type: Article

References (36)

1. Primary radiation therapy for early breast cancer
2. Inflammatory carcinoma of the breast: A pathological definition
3. Inflammatory carcinoma of the breast
4. Management of locally advanced and inflammatory carcinoma of the breast
5. Inflammatory carcinoma of the breast
6. Inflammatory carcinoma of the breast
7. Pathologic types of breast cancer: Their prognoses
8. Inflammatory carcinoma of the breast: A critique of therapy
9. Multimodality therapy of stage III adenocarcinoma of the breast
10. Inflammatory carcinoma of the breast
11. Inflammatory carcinoma of the breast: Clinical review and summary of the Vanderbilt experience with multimodality therapy
12. Management of inflammatory carcinoma of the breast with combined modality approach: An uptake
13. Traitement des cancers du sein inflammatories: Etude controlée d'un programme d'association thérapeutique
14. Chemotherapy of breast cancer: A general overview
15. Primary inflammatory carcinoma of the female breast: Staging and treatment possibilities
16. Phase I/II study of concurrent radiotherapy and multidrug chemotherapy in advanced carcinoma of the breast
17. Cancer inflammatoire du sein traité par une association de chimiothérapie et d'irradiation
18. Inflammatory breast cancer treated with surgery, chemotherapy and allogenic tumor cell/BCG immunotherapy
19. Host resistance and survival in carcinoma of breast: A study of 104 cases of medullary carcinoma in a series of 1411 cases of breast cancer followed for 20 years
20. Treatment of inflammatory carcinoma of the breast
21. Multimodal treatment in operable breast cancer: Five years results of CMF program
22. Adjuvant CMF in breast cancer: Comparative 5 years results of 12 versus 6 cycles
23. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy
24. Inflammatory breast carcinoma treated by radical radiotherapy
25. Surgical management of primary breast cancer
26. Two years of high dose cyclophosphamide and 5‐fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas
27. Initial chemotherapy in inflammatory carcinoma of the breast
28. Cancer inflammatoire du sein: Bilan à six ans de 16 malades traitées par immunochi‐miothérapie première
29. Traitement combiné des cancers mammaires localisés à haut risque métastatique: Résultats d'une étude prospective controlée
30. Breast cancer estrogen and progesterone receptor values: Their distribution, degree of concordance and relation to number of positive axillary nodes
31. Les cancers du sein inflammatoires: Corrélation entre anatomopathologie et dosage des récepteurs stéroidiens
32. Recepteurs à oestradiol et à progesterone dans le cancer du sein locorégional
33. Estrogen receptor: A prognostic factor in breast cancer
34. Pathological assessment of response to induction chemotherapy in breast cancer
35. Chimio‐therapie première dans le traitement des cancers du sein inflammatoires